DZ2227A1 - Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant. - Google Patents

Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant.

Info

Publication number: DZ2227A1
Authority: DZ; Algeria
Prior art keywords: preparation; pharmaceutical formulations; formulations containing; indole derivatives; new indole
Prior art date: 1996-05-09

Application number

DZ970074A

Other languages

English (en)

Inventor

David James Rawson

Kevin Nep Dack

Roger Peter Dickinson

James Kim

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-09

Filing date

1997-05-07

Publication date

2002-12-25

1997-05-07 Application filed by Pfizer filed Critical Pfizer

2002-12-25 Application granted granted Critical

2002-12-25 Publication of DZ2227A1 publication Critical patent/DZ2227A1/fr

Links

229940054051 antipsychotic indole derivative Drugs 0.000 title 1
150000002475 indoles Chemical class 0.000 title 1
238000000034 method Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

DZ970074A 1996-05-09 1997-05-07 Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant. DZ2227A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9609641.7A GB9609641D0 (en)	1996-05-09	1996-05-09	Compounds useful in therapy

Publications (1)

Publication Number	Publication Date
DZ2227A1 true DZ2227A1 (fr)	2002-12-25

Family

ID=10793387

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ970074A DZ2227A1 (fr)	1996-05-09	1997-05-07	Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant.

Country Status (42)

Country	Link
US (4)	US6017945A (fr)
EP (1)	EP0901470B1 (fr)
JP (1)	JP3245179B2 (fr)
KR (1)	KR100331217B1 (fr)
CN (1)	CN1124262C (fr)
AP (1)	AP830A (fr)
AR (1)	AR007030A1 (fr)
AT (1)	ATE263151T1 (fr)
AU (1)	AU717849B2 (fr)
BG (1)	BG102873A (fr)
BR (1)	BR9709072A (fr)
CA (1)	CA2253876A1 (fr)
CO (1)	CO4650036A1 (fr)
CZ (1)	CZ292928B6 (fr)
DE (1)	DE69728392T2 (fr)
DK (1)	DK0901470T3 (fr)
DZ (1)	DZ2227A1 (fr)
EA (1)	EA001471B1 (fr)
ES (1)	ES2218675T3 (fr)
GB (1)	GB9609641D0 (fr)
HN (1)	HN1997000058A (fr)
HR (1)	HRP970249B1 (fr)
HU (1)	HUP9901245A3 (fr)
ID (1)	ID16878A (fr)
IL (1)	IL125903A0 (fr)
IS (1)	IS1856B (fr)
MA (1)	MA26428A1 (fr)
NO (1)	NO312547B1 (fr)
NZ (1)	NZ332640A (fr)
OA (1)	OA10896A (fr)
PE (1)	PE65098A1 (fr)
PL (1)	PL329725A1 (fr)
PT (1)	PT901470E (fr)
SI (1)	SI0901470T1 (fr)
SK (1)	SK150398A3 (fr)
TN (1)	TNSN97078A1 (fr)
TR (1)	TR199802269T2 (fr)
TW (1)	TW491838B (fr)
UA (1)	UA50767C2 (fr)
UY (1)	UY24546A1 (fr)
WO (1)	WO1997043260A1 (fr)
ZA (1)	ZA973963B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9722287D0 (en) *	1997-10-22	1997-12-17	Pfizer Ltd	Compounds useful in therapy
EE05345B1 (et)	1999-02-10	2010-10-15	Astrazeneca Ab	Kinasoliini derivaadid angiogeneesi inhibiitoritena
GB0016162D0 (en) *	2000-06-30	2000-08-23	Cancer Res Campaign Tech	Indole-3-acetic acid derivatives
US20050203166A1 (en) *	2000-06-30	2005-09-15	Cancer Research Technology Limited	Indole-3-acetic acid derivatives
US7074817B2 (en)	2001-06-20	2006-07-11	Wyeth	Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
TWI224101B (en)	2001-06-20	2004-11-21	Wyeth Corp	Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
AR037097A1 (es)	2001-10-05	2004-10-20	Novartis Ag	Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
EP1569899B1 (fr)	2002-12-10	2006-06-28	Wyeth	Derives substitues de l'acide 3-alkyl- et 3-arylalkyl-1h-indol-1-yl-acetique en tant qu'inhibiteurs de l'inhibiteur de l'activateur du plasminogene-1 (pai-1)
US7078429B2 (en)	2002-12-10	2006-07-18	Wyeth	Substituted 3-carbonyl-1H-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
WO2004052854A2 (fr)	2002-12-10	2004-06-24	Wyeth	Derives d'acide 1h-indol-3-yl glyoxylique a substitution aryle, aryloxy et alkyloxy en tant qu'inhibiteurs de l'inhibiteur de l'activateur du plasminogene-1 (pai-1)
WO2004052856A1 (fr)	2002-12-10	2004-06-24	Wyeth	Derives d'acide indole oxo-acetyl amino acetique substitue comme inhibiteurs d'inhibiteur-1 de l'activateur du plasminogene (pai-1)
UA80453C2 (en)	2002-12-10	2007-09-25		Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
BRPI0406883A (pt) *	2003-01-22	2006-01-03	Lilly Co Eli	Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
US7342039B2 (en)	2003-09-25	2008-03-11	Wyeth	Substituted indole oximes
US7163954B2 (en)	2003-09-25	2007-01-16	Wyeth	Substituted naphthyl benzothiophene acids
US7420083B2 (en)	2003-09-25	2008-09-02	Wyeth	Substituted aryloximes
US7351726B2 (en)	2003-09-25	2008-04-01	Wyeth	Substituted oxadiazolidinediones
US7332521B2 (en)	2003-09-25	2008-02-19	Wyeth	Substituted indoles
US7265148B2 (en)	2003-09-25	2007-09-04	Wyeth	Substituted pyrrole-indoles
US7534894B2 (en)	2003-09-25	2009-05-19	Wyeth	Biphenyloxy-acids
US7442805B2 (en)	2003-09-25	2008-10-28	Wyeth	Substituted sulfonamide-indoles
US7582773B2 (en)	2003-09-25	2009-09-01	Wyeth	Substituted phenyl indoles
US7268159B2 (en)	2003-09-25	2007-09-11	Wyeth	Substituted indoles
US7446201B2 (en)	2003-09-25	2008-11-04	Wyeth	Substituted heteroaryl benzofuran acids
US7141592B2 (en)	2003-09-25	2006-11-28	Wyeth	Substituted oxadiazolidinediones
US7411083B2 (en)	2003-09-25	2008-08-12	Wyeth	Substituted acetic acid derivatives
JP2005109006A (ja) *	2003-09-29	2005-04-21	Tdk Corp	高電圧貫通型コンデンサ及びマグネトロン
HN2004000536A (es) *	2003-12-16	2009-02-18	Wyeth Corp	Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
WO2006023864A1 (fr)	2004-08-23	2006-03-02	Wyeth	Acides pyrrolo-naphtyliques en tant qu’inhibiteurs du pai-1
WO2006023866A2 (fr)	2004-08-23	2006-03-02	Wyeth	Acides thiazolo-naphthyliques
MX2007002178A (es)	2004-08-23	2007-04-02	Wyeth Corp	Acidos de oxazolo-naftilo como moduladores del inhibidor del activador de plasminogeno tipo 1 (pai-1) util en el tratamiento de trombosis y enfermedades cardiovasculares.
US7683091B2 (en)	2005-08-17	2010-03-23	Wyeth	Substituted indoles and methods of their use
WO2007119214A2 (fr) *	2006-04-13	2007-10-25	Actelion Pharmaceuticals Ltd	Traitement précoce de fibrose pulmonaire idiopathique
DE102008030207A1 (de)	2008-06-25	2009-12-31	Bayer Schering Pharma Aktiengesellschaft	Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung
DE102008030206A1 (de)	2008-06-25	2009-12-31	Bayer Schering Pharma Aktiengesellschaft	3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung
EP3519816A4 (fr)	2016-09-29	2020-05-06	The Regents of the University of California	Composés pour l'augmentation de la plasticité neuronale
CN106674065A (zh) *	2016-12-07	2017-05-17	贵州大学	一种5‑卤代‑2‑烷氧基‑4‑甲苯磺酰氯制备方法
GB201817038D0 (en) *	2018-10-19	2018-12-05	Inflazome Ltd	Novel processes
KR102946120B1 (ko)	2019-02-27	2026-03-30	더 리젠츠 오브 더 유니버시티 오브 캘리포니아	뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클
WO2022221415A2 (fr)	2021-04-13	2022-10-20	The Regents Of The University Of California	Composés tétracycliques pour le traitement de troubles cérébraux
JP2025502615A (ja)	2021-12-15	2025-01-28	デリックスセラピューティクス，インク．	フェノキシおよびベンジルオキシ置換サイコプラストゲンならびにその使用
CN117263832B (zh) *	2023-08-18	2026-02-03	辽宁龙田化工科技有限公司	一种2-氯-4-甲磺酰基苯甲酸合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE637355A (fr) *	1962-09-14
DE1950346B2 (de) *	1968-10-08	1973-06-28	Sumitomo Chemical Co	2-indolylessigsaeureverbindungen und diese verbindungen enthaltende arzneipraeparate
US4397079A (en) *	1981-03-30	1983-08-09	International Business Machines Corp.	Process for improving the yield of integrated devices including Schottky barrier diodes
US5245046A (en) *	1988-11-14	1993-09-14	The Upjohn Company	α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
AU8641991A (en)	1990-09-10	1992-03-30	Rhone-Poulenc Rorer International (Holdings) Inc.	Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
ZA939516B (en) *	1992-12-22	1994-06-06	Smithkline Beecham Corp	Endothelin receptor antagonists
ES2141197T3 (es) *	1993-03-19	2000-03-16	Merck & Co Inc	Derivados del acido fenoxifenilacetico.
GB9317096D0 (en) *	1993-08-17	1993-09-29	Pfizer Ltd	Indoles

1996
- 1996-05-09 GB GBGB9609641.7A patent/GB9609641D0/en active Pending
1997
- 1997-04-01 TW TW086104171A patent/TW491838B/zh not_active IP Right Cessation
- 1997-04-11 EP EP97920690A patent/EP0901470B1/fr not_active Expired - Lifetime
- 1997-04-11 KR KR1019980709023A patent/KR100331217B1/ko not_active Expired - Fee Related
- 1997-04-11 WO PCT/EP1997/001882 patent/WO1997043260A1/fr not_active Ceased
- 1997-04-11 DK DK97920690T patent/DK0901470T3/da active
- 1997-04-11 BR BR9709072A patent/BR9709072A/pt active Search and Examination
- 1997-04-11 AU AU26978/97A patent/AU717849B2/en not_active Ceased
- 1997-04-11 PT PT97920690T patent/PT901470E/pt unknown
- 1997-04-11 ES ES97920690T patent/ES2218675T3/es not_active Expired - Lifetime
- 1997-04-11 DE DE1997628392 patent/DE69728392T2/de not_active Expired - Fee Related
- 1997-04-11 JP JP54042397A patent/JP3245179B2/ja not_active Expired - Fee Related
- 1997-04-11 CN CN97194016A patent/CN1124262C/zh not_active Expired - Fee Related
- 1997-04-11 NZ NZ332640A patent/NZ332640A/en unknown
- 1997-04-11 IL IL12590397A patent/IL125903A0/xx unknown
- 1997-04-11 TR TR1998/02269T patent/TR199802269T2/xx unknown
- 1997-04-11 UA UA98115906A patent/UA50767C2/uk unknown
- 1997-04-11 CZ CZ19983582A patent/CZ292928B6/cs not_active IP Right Cessation
- 1997-04-11 PL PL97329725A patent/PL329725A1/xx unknown
- 1997-04-11 US US09/147,096 patent/US6017945A/en not_active Expired - Fee Related
- 1997-04-11 HU HU9901245A patent/HUP9901245A3/hu unknown
- 1997-04-11 AT AT97920690T patent/ATE263151T1/de not_active IP Right Cessation
- 1997-04-11 CA CA002253876A patent/CA2253876A1/fr not_active Abandoned
- 1997-04-11 EA EA199800908A patent/EA001471B1/ru not_active IP Right Cessation
- 1997-04-11 SI SI9730646T patent/SI0901470T1/xx unknown
- 1997-04-11 SK SK1503-98A patent/SK150398A3/sk unknown
- 1997-04-29 HN HN1997000058A patent/HN1997000058A/es unknown
- 1997-05-02 PE PE1997000345A patent/PE65098A1/es not_active Application Discontinuation
- 1997-05-07 ID IDP971517A patent/ID16878A/id unknown
- 1997-05-07 CO CO97024471A patent/CO4650036A1/es unknown
- 1997-05-07 DZ DZ970074A patent/DZ2227A1/fr active
- 1997-05-07 AR ARP970101888A patent/AR007030A1/es not_active Application Discontinuation
- 1997-05-07 UY UY24546A patent/UY24546A1/es not_active IP Right Cessation
- 1997-05-07 TN TNTNSN97078A patent/TNSN97078A1/fr unknown
- 1997-05-07 MA MA24599A patent/MA26428A1/fr unknown
- 1997-05-08 ZA ZA973963A patent/ZA973963B/xx unknown
- 1997-05-08 AP APAP/P/1997/000982A patent/AP830A/en active
- 1997-05-09 HR HR970249A patent/HRP970249B1/xx not_active IP Right Cessation
1998
- 1998-08-28 IS IS4838A patent/IS1856B/is unknown
- 1998-10-09 OA OA9800192A patent/OA10896A/en unknown
- 1998-10-27 BG BG102873A patent/BG102873A/xx unknown
- 1998-11-09 NO NO19985225A patent/NO312547B1/no not_active IP Right Cessation
1999
- 1999-10-07 US US09/414,361 patent/US6136843A/en not_active Expired - Fee Related
2000
- 2000-04-24 US US09/556,651 patent/US6306852B1/en not_active Expired - Fee Related
2001
- 2001-01-09 US US09/756,835 patent/US6384070B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AR007030A1 (es)	1999-10-13
ID16878A (id)	1997-11-20
TNSN97078A1 (fr)	2005-03-15
ATE263151T1 (de)	2004-04-15
ZA973963B (en)	1998-11-09
CN1124262C (zh)	2003-10-15
US6384070B2 (en)	2002-05-07
HRP970249B1 (en)	2003-06-30
HRP970249A2 (en)	1998-06-30
CZ358298A3 (cs)	1999-08-11
HUP9901245A2 (hu)	1999-08-30
SK150398A3 (en)	1999-03-12
KR100331217B1 (ko)	2002-05-09
EP0901470B1 (fr)	2004-03-31
IL125903A0 (en)	1999-04-11
DE69728392T2 (de)	2005-01-13
HN1997000058A (es)	1997-06-26
HUP9901245A3 (en)	2002-01-28
CN1216531A (zh)	1999-05-12
EP0901470A1 (fr)	1999-03-17
UY24546A1 (es)	2000-09-29
ES2218675T3 (es)	2004-11-16
OA10896A (en)	2001-10-11
EA199800908A1 (ru)	1999-06-24
IS4838A (is)	1998-08-28
US20010014677A1 (en)	2001-08-16
PL329725A1 (en)	1999-04-12
AU717849B2 (en)	2000-04-06
DE69728392D1 (de)	2004-05-06
HK1019149A1 (en)	2000-01-14
AU2697897A (en)	1997-12-05
KR20000010879A (ko)	2000-02-25
JP3245179B2 (ja)	2002-01-07
BG102873A (en)	1999-11-30
AP9700982A0 (en)	1997-07-31
AP830A (en)	2000-05-03
DK0901470T3 (da)	2004-07-12
CZ292928B6 (cs)	2004-01-14
MA26428A1 (fr)	2004-12-20
NO985225D0 (no)	1998-11-09
SI0901470T1 (en)	2004-08-31
CO4650036A1 (es)	1998-09-03
US6017945A (en)	2000-01-25
EA001471B1 (ru)	2001-04-23
NO312547B1 (no)	2002-05-27
TR199802269T2 (xx)	2001-12-21
PT901470E (pt)	2004-07-30
JPH11508285A (ja)	1999-07-21
TW491838B (en)	2002-06-21
PE65098A1 (es)	1998-10-29
IS1856B (is)	2003-02-21
US6306852B1 (en)	2001-10-23
WO1997043260A1 (fr)	1997-11-20
UA50767C2 (uk)	2002-11-15
US6136843A (en)	2000-10-24
CA2253876A1 (fr)	1997-11-20
BR9709072A (pt)	1999-08-03
GB9609641D0 (en)	1996-07-10
NO985225L (no)	1998-11-09
NZ332640A (en)	2001-03-30

Publication	Publication Date	Title
DZ2303A1 (fr)	2002-12-28	Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2300A1 (fr)	2002-12-25	Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr)	2002-12-25	Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26428A1 (fr)	2004-12-20	Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant
DZ1889A1 (fr)	2002-02-17	Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1957A1 (fr)	2002-02-17	Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26659A1 (fr)	2004-12-20	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2128A1 (fr)	2002-10-26	Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3042A1 (fr)	2004-03-27	Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2581A1 (fr)	2003-02-22	Dérivés d'acides aryloxyarylsulfonylaminohydroxamiques procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2745A1 (fr)	2003-09-08	BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26526A1 (fr)	2004-12-20	Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ2523A1 (fr)	2003-02-01	Formulations pharmaceutiques contenant du voriconazole et procédé pour leur préparation.
DZ2963A1 (fr)	2004-03-15	Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2758A1 (fr)	2003-09-15	Dérivés bicycliques d0acide hydroxamique nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2870A1 (fr)	2003-12-15	Dérivés d'acide hydroxypipécolate-hydroxamique nouveaux, procédé pour leur préparation et compositi ons pharmaceutiques les contenant.
FR2740136B1 (fr)	1998-01-09	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
DZ2777A1 (fr)	2003-12-01	Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2962A1 (fr)	2004-03-15	Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ2550A1 (fr)	2003-02-08	Dérivés d'azétidinylpropylpipéridine procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2217A1 (fr)	2002-12-03	Dérivés d'imidazole substitués, procédé pour leur préparation et compositions les contenant.
MA26414A1 (fr)	2004-12-20	Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.